Article info
Diagnostics
Original research
Homozygous hypomorphic BRCA2 variant in primary ovarian insufficiency without cancer or Fanconi anaemia trait
- Correspondence to Professor Micheline Misrahi, Université Paris Saclay Faculté de Medecine, Hôpital Bicêtre APHP, Le Kremlin-Bicetre, France; micheline.misrahi{at}aphp.fr; Dr Bernard S Lopez; bernard.lopez{at}inserm.fr
Citation
Homozygous hypomorphic BRCA2 variant in primary ovarian insufficiency without cancer or Fanconi anaemia trait
Publication history
- Received November 5, 2019
- Revised April 8, 2020
- Accepted April 12, 2020
- First published June 1, 2020.
Online issue publication
January 22, 2021
Article Versions
- Previous version (22 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.